Please login to the form below

Not currently logged in
Email:
Password:

Repositive appoints scientific lead

Manuel Corpas joins the genome software company

Repositive Manuel CorpasCambridge, UK-based Repositive has appointed Manuel Corpas as its scientific lead.

In his new role, Corpas will be responsible for building awareness in the scientific community around Repositive's platform through workshops and key event presentations.

He joins the human genomic research data software developer from The Genome Analysis Centre, where he served as project leader for plant and animal genomes.

During this time, Corpas was also the board director for the International Society for Computational Biology and served as the ELIXIR-UK technical coordinator.

Prior to this, he held a number of roles at the European Bioinfomatics Institute, Sanger and the Spanish National Bioinformatics Centre.

Fiona Nielson, chief executive officer of Repositive, said: “Manny will be a great addition to the team, and is perfect for helping us increase awareness of Repositive in the scientific community.

“He has build an incredibly strong reputation for both innovate science and promoting the benefits of collaboration, and his experience and connections will be crucial in building Repositive as the go-to platform for human genomic data.”

6th September 2016

From: Research

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Origins Insights

Origins are part of the Resonant Group. Using novel research methodologies, we dig deeper to deliver authentic audience experiences that...

Latest intelligence

Is communication failing us?
Compelling people to care in a world oversaturated with news and information...
Are your field teams ready to excel in the new era?
A qualitative research approach to help you critically assess post-pandemic learnings and ignite the potential of meaningful interactions with HCPs....
5 Healthcare Marketing Blunders | How To Avoid Them.
Here are 5 healthcare marketing blunders and how best to avoid them....